169 AGGRECANASE-1 ACTIVITY IN THE SYNOVIAL FLUID OF CARTILAGE INJURY CELL THERAPY TRIAL COHORT PREDICTS OUTCOME 1-YEAR POST TREATMENT.
(2024)
Presentation / Conference
Rix, L., Hulme, C. H., Kuiper, J. H., Mennan, C., Gallacher, P., Jermin, P., & Wright, K. T. (2024, January). 169 AGGRECANASE-1 ACTIVITY IN THE SYNOVIAL FLUID OF CARTILAGE INJURY CELL THERAPY TRIAL COHORT PREDICTS OUTCOME 1-YEAR POST TREATMENT. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria
All Outputs (2)
Extracellular vesicles derived from umbilical cord mesenchymal stromal cells show enhanced anti-inflammatory properties via upregulation of miRNAs after pro-inflammatory priming (2023)
Journal Article
Hyland, M., Mennan, C., Davies, R., Wilson, E., Tonge, D. P., Clayton, A., & Kehoe, O. (2023). Extracellular vesicles derived from umbilical cord mesenchymal stromal cells show enhanced anti-inflammatory properties via upregulation of miRNAs after pro-inflammatory priming. Stem Cell Reviews and Reports, 19, 2391ā2406. https://doi.org/10.1007/s12015-023-10586-2Autoimmune conditions, such as rheumatoid arthritis, are characterised by a loss of immune tolerance, whereby the immune cells attack self-antigens causing pain and inflammation. These conditions can be brought into remission using pharmaceutical tre... Read More about Extracellular vesicles derived from umbilical cord mesenchymal stromal cells show enhanced anti-inflammatory properties via upregulation of miRNAs after pro-inflammatory priming.